Be The Match BioTherapies And Cryoport Partner To Accelerate The Development Of Cell And Gene Therapies
Portfolio Pulse from Benzinga Newsdesk
Be The Match BioTherapies and Cryoport have announced a partnership to accelerate the development of cell and gene therapies. The partnership will provide access to standardized and optimized apheresis collection, cryopreservation and bioprocessing processes throughout the U.S. and Europe.
October 09, 2023 | 8:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cryoport's partnership with Be The Match BioTherapies could potentially boost its position in the cell and gene therapy market, potentially leading to increased revenues.
The partnership with Be The Match BioTherapies could potentially expand Cryoport's reach and influence in the cell and gene therapy market. This could lead to increased demand for its services, potentially driving up revenues and positively impacting its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100